Sign in to fuzzto save your conversations, follow your research and come back anytime.
Bafna Pharmaceuticals
SectorHealthcare
| Metric (₹ crore) | Q1 FY19 | Q2 FY19 | Q1 FY20 | Q2 FY20 |
|---|---|---|---|---|
| Sales | 11.95 | 8.84 | 6.85 | 11.57 |
| Expenses | 13.77 | 8.65 | 9.72 | 11.94 |
| EBITDA | -1.82 | 0.19 | -2.87 | -0.37 |
| Depreciation | 1 | 0.75 | 1.02 | 0.72 |
| EBIT | -2.82 | -0.56 | -3.89 | -1.09 |
| Interest | 0.83 | 0.62 | 0.13 | 0.04 |
| Profit Before Tax | -3.65 | -1.18 | -4.02 | -1.13 |
| Net Profit | -3.52 | -1.28 | -2.13 | -0.59 |
| EPS | 0 | -0.8 | -0.9 | -0.25 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 10.66 | 0.91 | -0.95 | -7.05 | -1.79 | -34.31 |
| Investing Cash Flow | 60.13 | -0.36 | -5.42 | 37.97 | 15.36 | 32.77 |
| Financing Cash Flow | -70.83 | -0.61 | 6.31 | -30.63 | -13.81 | 7.3 |
| Net Cash Flow | -0.04 | -0.06 | -0.06 | 0.29 | -0.24 | 5.76 |
| Metric (₹ crore) | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 |
|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 72.71 | 57.75 | 42.12 | 37.2 | 18.85 | 51.19 |
| Total Liabilities | 127.12 | 134.95 | 136.2 | 101.16 | 100.62 | 20.12 |
| Total Assets | 199.83 | 192.71 | 178.31 | 138.36 | 119.47 | 71.31 |